Enhancing the opportunities for cholangiocarcinoma precision therapy

Reka Toth; Paul J Brindley; Javier Vaquero

doi:10.1136/gutjnl-2023-331480

Enhancing the opportunities for cholangiocarcinoma precision therapy

Reka Toth
, Paul J Brindley
, Javier Vaquero^*

^*Corresponding author for this work

Multiomics Data Science

Research output: Contribution to journal › Comment/debate

2 Citations (Scopus)

Original language	English
Pages (from-to)	888-889
Number of pages	2
Journal	Gut
Volume	73
Issue number	6
Early online date	16 Jan 2024
DOIs	https://doi.org/10.1136/gutjnl-2023-331480
Publication status	Published - 10 May 2024

Access to Document

10.1136/gutjnl-2023-331480

Cite this

@article{d4ca5b8cdf624bcb9a13082b8c59f640,

title = "Enhancing the opportunities for cholangiocarcinoma precision therapy",

author = "Reka Toth and Brindley, \{Paul J\} and Javier Vaquero",

note = "PJB ackowledges support from the National Cancer Institute, NIH award R01CA164719.PJB ackowledges support from the National Cancer Institute, NIH award R01CA164719",

year = "2024",

month = may,

day = "10",

doi = "10.1136/gutjnl-2023-331480",

language = "English",

volume = "73",

pages = "888--889",

journal = "Gut",

issn = "0017-5749",

publisher = "BMJ Publishing Group",

number = "6",

}

TY - JOUR

T1 - Enhancing the opportunities for cholangiocarcinoma precision therapy

AU - Toth, Reka

AU - Brindley, Paul J

AU - Vaquero, Javier

N1 - PJB ackowledges support from the National Cancer Institute, NIH award R01CA164719.PJB ackowledges support from the National Cancer Institute, NIH award R01CA164719

PY - 2024/5/10

Y1 - 2024/5/10

UR - https://pubmed.ncbi.nlm.nih.gov/38228376

U2 - 10.1136/gutjnl-2023-331480

DO - 10.1136/gutjnl-2023-331480

M3 - Comment/debate

C2 - 38228376

SN - 0017-5749

VL - 73

SP - 888

EP - 889

JO - Gut

JF - Gut

IS - 6

ER -

Enhancing the opportunities for cholangiocarcinoma precision therapy

Access to Document

Other files and links

Cite this